No definition available.
Other specified and unspecified disorders of conjunctiva
DOID EFO Endpoint Browser PheWeb
H7_CONJUNAS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
329 |
4. Check minimum number of eventsNone |
329 |
5. Include endpointsNone |
329 |
6. Filter based on genotype QC (FinnGen only) |
329 |
Control definitions (FinnGen only)
- Control exclude
- H7_CONJUNCTIVA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified and unspecified disorders of conjunctiva
based on the number of shared cases.
Similar with more cases:
- Other disorders of conjunctiva
- Disorders of conjunctiva
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2409 | 1232 | 1163 |
| Only index persons | 2216 | 1153 | 1063 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.03 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 49.21 | 51.60 | 46.86 |
| Only index persons | 50.48 | 52.87 | 47.88 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 329 | 184 | 145 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | 58.44 | 56.88 | 60.41 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 281
- Matched controls
- 2811
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H11.8
ICD-10 Finland
Other specified disorders of conjunctiva
2644.5
156.8
137
*
H11.9
ICD-10 Finland
Disorder of conjunctiva, unspecified
+∞
144.6
126
*
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
433.3
39.1
38
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
393.8
35.8
35
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.2
18.8
144
692
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
3.0
15.5
123
585
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
21.6
15.4
22
11
3728X
ICD-9 Finland
Disorders of conjunctiva, Other disorders of conjunctiva
+∞
13.6
13
*
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
+∞
13.6
13
*
S01GX01
ATC
cromoglicic acid; ophthalmic
3.8
13.6
62
194
CD2S4
NOMESCO Finland
Photography of eye
42.3
13.3
16
*
H04.10
ICD-10 Finland
Dry eye syndrome
4.6
12.7
45
111
CF2S4
NOMESCO Finland
Photography of conjunctiva
+∞
12.6
12
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.0
11.6
48
137
CBA10
NOMESCO Finland
Biopsy of eyelid
62.4
10.7
12
*
H11.0
ICD-10 Finland
Pterygium
+∞
10.5
10
*
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
9.4
9
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
5.9
9.2
25
46
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
5.2
8.6
26
54
S01XA18
ATC
ciclosporin; ophthalmic
92.7
8.5
9
*
F02
ICPC
Red eye
6.2
7.8
20
34
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
+∞
7.3
7
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.5
7.3
33
102
H01.0
ICD-10 Finland
Blepharitis
4.8
7.3
23
51
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.8
6.4
41
163
CFA12
NOMESCO Finland
Resection of conjunctiva
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
207
1534
1.94
7.62
10.9
9.4
4.0
4.1
e9/l
0.16
187
1349
43
183
2.55
6.81
5.8
3.8
99.5
76.3
ng/l
0.49
35
163
156
1088
1.83
6.61
7.7
4.5
35.5
35.6
g/l
0.06
140
1028
42
186
2.44
6.12
5.3
2.9
294.0
181.6
ng/l
0.57
42
170
162
1167
1.76
5.97
11.6
5.9
1.2
1.2
mmol/l
0.02
145
1074
84
500
1.91
5.76
5.4
3.7
958.2
246.2
ng/l
0.36
58
392
203
1570
1.77
5.75
8.6
4.7
6.6
6.6
mmol/l
0.06
190
1453
103
667
1.79
5.36
3.0
2.6
347.1
5510.8
umol/l
2.46
94
577
55
295
2.04
5.04
2.1
1.7
—
—
—
0
0
302
2707
2.41
4.80
21.2
13.5
21.1
23.9
mg/l
0.88
234
2107
55
302
1.99
4.72
2.1
1.7
—
—
—
0
0
106
716
1.71
4.66
4.1
3.1
1622.7
1188.8
ng/l
0.41
90
609
242
2035
1.72
4.44
10.1
7.4
77.9
80.0
u/l
0.37
233
1915
17
55
3.20
4.43
15.9
4.8
547.8
616.8
iu/ml
—
5
8
239
2006
1.70
4.38
5.2
3.7
14.8
14.8
pmol/l
0.17
214
1806
68
412
1.82
4.32
2.2
1.8
—
—
—
0
0
15
46
3.37
4.24
1.5
1.3
—
—
—
0
0
86
569
1.69
4.01
4.0
1.7
2.6
1.3
mg/l
0.41
67
440
164
1272
1.58
4.01
14.4
6.6
1.2
1.2
mmol/l
0.54
147
1077
121
880
1.59
3.86
5.0
3.3
2.4
2.4
mmol/l
0.14
104
779
233
1974
1.62
3.80
4.9
3.8
11.0
12.1
mm/h
0.58
220
1816
149
1143
1.55
3.75
3.3
2.6
139.3
118.3
ug/l
0.51
141
1051
135
1016
1.56
3.68
2.3
1.9
90.3
93.4
pmol/l
0.28
66
507
139
1057
1.55
3.60
2.5
2.3
78.8
77.2
nmol/l
0.28
122
949
276
2457
1.77
3.56
6.0
4.4
1.9
1.9
mu/l
0.05
249
2230
176
1415
1.52
3.49
8.6
6.2
11.2
11.1
umol/l
0.04
168
1344
15
55
2.81
3.20
1.3
1.3
—
—
—
0
0
14
51
2.82
3.02
2.1
1.4
114.0
99.5
u/ml
—
5
11
106
784
1.52
3.02
3.1
2.0
213.2
299.2
u/l
0.35
98
738
123
942
1.49
2.95
4.7
3.0
—
—
—
0
0
9
23
3.99
2.79
3.2
2.3
—
—
—
0
0
29
155
1.96
2.71
17.6
4.7
25.1
24.9
mmol/l
0.11
29
155
205
1753
1.45
2.68
3.3
3.0
—
—
—
0
0
56
371
1.61
2.55
3.6
2.1
2.2
2.4
g/l
1.05
51
347
68
472
1.56
2.55
1.8
1.7
986.2
1209.8
nmol/l
1.47
54
351
63
430
1.58
2.54
2.7
2.7
0.6
0.9
e6/l
0.44
42
240
53
347
1.63
2.53
3.7
2.2
23.9
23.6
%
0.05
42
306
9
26
3.53
2.50
1.8
1.6
13.6
13.1
%
—
9
26
129
1024
1.43
2.48
4.4
3.6
58.0
66.0
ng/l
0.08
84
708
42
262
1.69
2.41
3.7
2.2
42.6
213.8
u/l
0.46
35
223
10
35
2.92
2.32
1.1
1.1
—
—
—
0
0
7
18
3.95
2.26
1.7
3.1
596.6
652.5
u/ml
—
7
18
16
73
2.25
2.25
1.6
1.2
—
—
—
0
0
13
54
2.47
2.22
3.6
1.6
4.5
6.4
iu/l
—
6
16
96
737
1.43
2.18
4.1
2.9
0.4
0.5
e6/l
0.42
77
553
61
429
1.52
2.15
8.2
3.5
0.8
0.8
mmol/l
0.27
55
404
13
55
2.42
2.15
1.2
1.3
—
—
—
0
0
13
55
2.42
2.15
1.2
1.3
—
—
—
0
0
58
405
1.52
2.12
2.9
2.9
3.7
1.9
e6/l
0.70
37
218
17
82
2.13
2.11
1.6
2.2
620.0
5509.8
u/l
—
9
29
65
466
1.49
2.10
2.6
3.0
2.5
2.5
mmol/l
0.02
54
411
15
71
2.17
1.95
2.1
1.5
—
—
—
0
0
148
1243
1.35
1.91
7.1
4.0
—
—
—
0
0
17
86
2.03
1.88
1.4
1.5
—
—
—
0
0
8
28
2.90
1.87
1.4
1.3
—
—
—
0
0
105
841
1.37
1.83
4.9
2.6
58.5
56.4
u/l
0.18
96
780
14
67
2.14
1.78
1.6
1.4
—
—
—
0
0
81
624
1.40
1.78
2.1
2.0
2.6
3.1
mg/l
1.85
70
542
10
41
2.48
1.77
1.1
1.4
—
—
—
0
0
12
54
2.27
1.76
1.3
1.5
—
—
—
0
0
9
36
2.54
1.75
1.7
1.3
—
—
—
0
0
7
24
2.96
1.73
1.1
1.2
—
—
—
0
0
80
618
1.39
1.73
1.8
1.5
24.3
20.9
nmol/l
0.59
70
515
14
68
2.11
1.73
1.1
1.4
—
—
—
0
0
5
13
3.89
1.72
1.4
1.5
—
—
—
0
0
5
13
3.89
1.72
1.4
1.5
—
—
—
0
0
5
13
3.89
1.72
1.0
1.1
—
—
—
0
0
14
69
2.07
1.67
1.6
1.4
—
—
—
0
0
15
80
1.92
1.47
1.4
1.3
—
—
—
0
0
79
626
1.34
1.45
2.9
2.2
—
—
—
0
0
267
2500
1.36
1.38
26.6
14.1
39.4
40.3
%
0.92
194
1846
10
47
2.16
1.35
1.4
1.5
—
—
—
0
0
0
39
0.00
1.34
0.0
1.4
—
7.7
—
0
30
283
2678
1.41
1.34
4.6
4.3
4.6
4.7
mmol/l
1.41
263
2482
277
2614
1.38
1.31
5.1
4.3
6.0
5.9
mmol/l
0.43
250
2385
282
2669
1.40
1.31
4.5
4.2
1.5
1.5
mmol/l
0.36
259
2462
26
170
1.57
1.30
1.1
1.2
146.2
122.9
iu/ml
—
9
69
5
18
2.80
1.29
1.0
1.2
—
—
—
0
0
16
92
1.78
1.27
1.2
1.1
—
—
—
0
0
16
92
1.78
1.27
1.2
1.1
—
—
—
0
0
8
36
2.25
1.25
1.0
1.2
—
—
—
0
0
201
1830
1.25
1.19
4.0
3.0
57.7
47.0
u/l
0.53
185
1713
6
26
2.33
1.19
1.7
1.5
—
—
—
0
0
8
39
2.08
1.16
1.5
1.5
—
—
—
0
0
272
2573
1.33
1.16
4.1
3.9
1.3
1.3
mmol/l
0.21
247
2371
79
650
1.28
1.11
3.4
4.2
25.0
22.0
%
0.63
33
291
63
503
1.31
1.10
1.6
1.5
—
—
—
0
0
23
153
1.54
1.09
1.8
1.8
—
—
—
0
0
286
2734
1.35
1.05
5.4
4.8
2.7
2.8
mmol/l
0.77
266
2521
10
53
1.91
1.02
1.5
1.3
—
—
—
0
0
24
165
1.49
1.00
1.3
1.3
—
—
—
0
0
5
23
2.19
0.98
1.4
1.2
—
—
—
0
0
147
1315
1.21
0.96
4.0
3.4
0.0
0.0
estimate
0.00
23
265
17
109
1.59
0.95
3.3
2.0
7.2
3.8
ug/l
0.30
17
101
15
93
1.64
0.95
1.3
1.5
241.0
236.4
miu/ml
—
5
45
19
126
1.54
0.93
8.3
2.2
1.2
1.3
%
0.13
19
126
32
238
1.38
0.90
21.3
5.7
1.2
1.4
mmol/l
0.60
32
230
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
71
1.72
0.90
13.6
2.3
0.2
0.3
u/ml
—
7
36
11
64
1.74
0.87
1.5
1.3
—
—
—
0
0
41
320
1.32
0.86
9.0
6.9
—
—
—
0
0
6
33
1.83
0.79
4.5
4.3
375.2
342.1
umol/l
—
6
28
8
48
1.68
0.79
1.4
1.1
—
—
—
0
0
28
210
1.36
0.77
1.7
2.6
61.9
67.1
ml/min/173m2
—
10
95
11
67
1.66
0.76
1.2
1.2
—
—
—
0
0
12
75
1.62
0.76
1.4
1.2
—
—
—
0
0
36
282
1.31
0.75
2.9
3.5
—
—
—
0
0
145
1320
1.18
0.74
5.2
4.5
0.0
0.0
estimate
0.50
23
259
26
194
1.37
0.74
1.5
1.5
—
—
—
0
0
261
2499
1.21
0.72
6.7
5.4
40.0
39.7
mmol/mol
0.20
243
2334
146
1334
1.17
0.70
4.0
3.4
0.0
0.0
estimate
0.00
22
250
7
41
1.72
0.70
1.0
1.5
—
—
—
0
0
21
153
1.40
0.69
1.4
1.7
—
—
—
0
0
22
162
1.38
0.68
1.3
1.3
—
—
—
0
0
16
111
1.46
0.67
3.0
1.9
1.5
1.6
g/l
0.11
16
97
7
44
1.60
0.65
1.1
1.2
214.3
14.5
u/l
—
7
37
7
44
1.60
0.65
1.0
1.0
—
—
—
0
0
14
95
1.49
0.65
2.0
2.0
—
—
—
0
0
5
29
1.73
0.64
1.6
1.7
—
—
—
0
0
61
522
1.21
0.62
1.5
1.8
238461941.3
445.6
pmol/l
0.49
52
437
16
114
1.42
0.60
2.8
2.0
2.0
2.7
mg/l
—
10
84
20
264
0.74
0.60
1.8
1.7
—
—
—
0
0
297
2895
1.27
0.59
14.2
9.9
26.1
26.6
u/l
0.17
291
2790
6
36
1.68
0.57
1.3
1.4
—
—
—
0
0
13
90
1.46
0.56
5.9
3.1
—
—
—
0
0
79
702
1.16
0.53
1.7
1.6
1.2
1.4
mmol/l
1.75
73
587
35
289
1.24
0.51
8.7
4.0
235.7
234.5
u/l
0.03
35
275
10
67
1.51
0.50
1.7
1.5
—
—
—
0
0
10
67
1.51
0.50
1.7
1.5
—
—
—
0
0
10
67
1.51
0.50
1.6
1.5
—
—
—
0
0
10
67
1.51
0.50
1.6
1.5
—
—
—
0
0
10
68
1.49
0.47
2.3
2.0
123.6
131.1
g/l
—
5
46
7
48
1.47
0.47
1.4
1.5
—
—
—
0
0
5
82
0.60
0.46
1.4
1.5
—
—
—
0
0
263
2550
1.16
0.46
17.6
12.5
80.0
82.3
ml/min/173m2
0.88
224
2077
56
492
1.17
0.44
2.2
2.7
0.6
0.8
ug/l
2.22
40
305
8
56
1.44
0.43
1.1
1.3
3.6
3.7
mmol/l
—
8
50
5
32
1.57
0.42
1.6
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
11
79
1.41
0.41
13.0
2.2
1863.8
831.3
ug/l
0.26
11
74
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
5
35
1.44
0.39
1.0
1.5
—
—
—
0
0
5
36
1.39
0.38
1.0
1.5
—
—
—
0
0
5
36
1.39
0.38
1.0
1.5
—
—
—
0
0
5
36
1.39
0.38
1.0
1.5
—
—
—
0
0
48
423
1.16
0.38
1.3
1.2
9.7
9.0
u/ml
0.03
22
165
5
37
1.36
0.37
1.0
1.5
—
—
—
0
0
5
37
1.36
0.37
1.0
1.5
—
—
—
0
0
91
839
1.12
0.37
4.1
4.5
1.5
2.0
ug/l
2.28
84
753
16
126
1.28
0.36
2.0
1.7
—
—
—
0
0
10
75
1.34
0.30
1.8
1.6
—
—
—
0
0
49
444
1.12
0.27
1.4
1.3
11.2
34.6
iu/ml
3.94
16
150
19
160
1.20
0.26
1.2
1.3
—
49.6
—
0
13
9
75
1.21
0.25
1.0
1.0
—
9.8
—
0
11
34
305
1.13
0.23
4.6
4.4
31.2
31.6
%
0.09
27
208
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
2.3
—
2.8
—
0
5
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
14
166
0.84
0.21
8.3
3.6
5.2
5.1
kpa
0.20
14
158
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
10
81
1.24
0.19
2.3
3.5
—
2.6
—
0
11
7
59
1.19
0.18
10.7
1.3
1.0
0.9
nmol/l
—
7
50
16
139
1.16
0.16
1.2
1.0
—
—
—
0
0
32
293
1.10
0.16
2.2
4.1
21.7
22.2
ug/l
0.01
23
246
63
599
1.06
0.14
1.4
1.2
0.4
1.1
u/ml
—
9
178
12
135
0.88
0.10
1.8
1.6
—
—
—
0
0
11
97
1.14
0.09
1.5
1.9
—
—
—
0
0
5
60
0.83
0.08
1.0
1.8
—
—
—
0
0
9
87
1.04
0.07
1.6
1.7
—
—
—
0
0
8
90
0.89
0.07
2.3
1.7
—
—
—
0
0
26
273
0.95
0.05
1.7
1.8
—
—
—
0
0
40
411
0.97
0.03
1.4
1.4
—
—
—
0
0
102
1030
0.99
0.02
4.5
3.4
—
—
—
0
0
30
301
1.00
0.00
1.8
1.9
—
—
—
0
0
73
734
0.99
0.00
5.1
3.6
0.0
0.0
estimate
0.50
22
257
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
6
64
0.94
0.00
3.0
2.3
23.0
24.9
mmol/l
—
6
56
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
9
94
0.96
0.00
2.0
1.9
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
0.00
1.2
1.7
—
—
—
0
0
6
61
0.98
0.00
2.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
4.8
—
60.3
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
1.3
—
0
7
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
6
64
0.94
0.00
1.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_CONJUNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUNAS | 0.931 [0.7, 1.24] | 0.623 |
| Birth year | 0.999 [0.99, 1.01] | 0.831 |
During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 895 females with H7_CONJUNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUNAS | 1.148 [0.85, 1.55] | 0.366 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 107 out of 871 males with H7_CONJUNAS died.
Mortality risk
Mortality risk for people of age
years, who have H7_CONJUNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.09% | 0.194% |
| 5 | 0.57% | 1.137% |
| 10 | 1.522% | 2.871% |
| 15 | 3.012% | 5.649% |
| 20 | 5.316% | 9.392% |
Relationships between endpoints
↥Index endpoint: H7_CONJUNAS – Other specified and unspecified disorders of conjunctiva
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data